nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—KCNJ1—appendage—muscle cancer	0.0927	0.473	CbGeAlD
Glimepiride—Gliclazide—VEGFA—muscle cancer	0.0386	1	CrCbGaD
Glimepiride—Paresis—Vincristine—muscle cancer	0.0264	0.0345	CcSEcCtD
Glimepiride—KCNJ1—renal system—muscle cancer	0.0233	0.119	CbGeAlD
Glimepiride—Eruption—Dactinomycin—muscle cancer	0.0175	0.0229	CcSEcCtD
Glimepiride—Inappropriate antidiuretic hormone secretion—Vincristine—muscle cancer	0.0166	0.0216	CcSEcCtD
Glimepiride—KCNJ1—head—muscle cancer	0.0156	0.0796	CbGeAlD
Glimepiride—Allergic cutaneous angiitis—Methotrexate—muscle cancer	0.0147	0.0192	CcSEcCtD
Glimepiride—Diabetic—Methotrexate—muscle cancer	0.014	0.0183	CcSEcCtD
Glimepiride—Reaction gastrointestinal—Methotrexate—muscle cancer	0.014	0.0183	CcSEcCtD
Glimepiride—ABCC8—smooth muscle tissue—muscle cancer	0.0135	0.0691	CbGeAlD
Glimepiride—ABCC8—renal system—muscle cancer	0.013	0.0665	CbGeAlD
Glimepiride—Paresis—Methotrexate—muscle cancer	0.0128	0.0167	CcSEcCtD
Glimepiride—KCNJ11—tendon—muscle cancer	0.011	0.0563	CbGeAlD
Glimepiride—Aplastic anaemia—Dactinomycin—muscle cancer	0.0101	0.0132	CcSEcCtD
Glimepiride—Laboratory test abnormal—Doxorubicin—muscle cancer	0.00969	0.0127	CcSEcCtD
Glimepiride—Leukocytoclastic vasculitis—Methotrexate—muscle cancer	0.00953	0.0124	CcSEcCtD
Glimepiride—KCNJ11—head—muscle cancer	0.00946	0.0483	CbGeAlD
Glimepiride—Coma—Vincristine—muscle cancer	0.0088	0.0115	CcSEcCtD
Glimepiride—ABCC8—head—muscle cancer	0.00871	0.0445	CbGeAlD
Glimepiride—Hepatic failure—Dactinomycin—muscle cancer	0.00871	0.0114	CcSEcCtD
Glimepiride—ABCC8—testis—muscle cancer	0.00842	0.043	CbGeAlD
Glimepiride—Hepatic failure—Vincristine—muscle cancer	0.00778	0.0102	CcSEcCtD
Glimepiride—Eruption—Methotrexate—muscle cancer	0.0076	0.00992	CcSEcCtD
Glimepiride—Aphasia—Methotrexate—muscle cancer	0.0072	0.00941	CcSEcCtD
Glimepiride—Hyponatraemia—Vincristine—muscle cancer	0.00702	0.00917	CcSEcCtD
Glimepiride—Pain in extremity—Vincristine—muscle cancer	0.00699	0.00913	CcSEcCtD
Glimepiride—Eruption—Doxorubicin—muscle cancer	0.00658	0.00859	CcSEcCtD
Glimepiride—Pancytopenia—Dactinomycin—muscle cancer	0.00642	0.00839	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.00598	0.00781	CcSEcCtD
Glimepiride—Pancytopenia—Vincristine—muscle cancer	0.00574	0.0075	CcSEcCtD
Glimepiride—Agranulocytosis—Dactinomycin—muscle cancer	0.00563	0.00735	CcSEcCtD
Glimepiride—Photosensitivity reaction—Vincristine—muscle cancer	0.00551	0.0072	CcSEcCtD
Glimepiride—Speech disorder—Methotrexate—muscle cancer	0.00543	0.0071	CcSEcCtD
Glimepiride—Hepatitis—Dactinomycin—muscle cancer	0.00541	0.00707	CcSEcCtD
Glimepiride—Sweating—Vincristine—muscle cancer	0.00516	0.00675	CcSEcCtD
Glimepiride—Hyperbilirubinaemia—Methotrexate—muscle cancer	0.00514	0.00671	CcSEcCtD
Glimepiride—Erythema multiforme—Dactinomycin—muscle cancer	0.00512	0.00669	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Etoposide—muscle cancer	0.00499	0.00652	CcSEcCtD
Glimepiride—Vasculitis—Methotrexate—muscle cancer	0.00479	0.00625	CcSEcCtD
Glimepiride—Sweating increased—Etoposide—muscle cancer	0.00477	0.00623	CcSEcCtD
Glimepiride—Erythema—Dactinomycin—muscle cancer	0.00471	0.00616	CcSEcCtD
Glimepiride—Delirium—Doxorubicin—muscle cancer	0.0047	0.00615	CcSEcCtD
Glimepiride—Pancytopenia—Etoposide—muscle cancer	0.00465	0.00607	CcSEcCtD
Glimepiride—Vasodilation—Doxorubicin—muscle cancer	0.0046	0.00602	CcSEcCtD
Glimepiride—Vasodilation procedure—Doxorubicin—muscle cancer	0.0046	0.00602	CcSEcCtD
Glimepiride—Hyperbilirubinaemia—Doxorubicin—muscle cancer	0.00445	0.00581	CcSEcCtD
Glimepiride—Aplastic anaemia—Methotrexate—muscle cancer	0.00439	0.00573	CcSEcCtD
Glimepiride—Nocturia—Doxorubicin—muscle cancer	0.00436	0.0057	CcSEcCtD
Glimepiride—Anaemia—Dactinomycin—muscle cancer	0.00436	0.00569	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00433	0.00565	CcSEcCtD
Glimepiride—Coma—Methotrexate—muscle cancer	0.00427	0.00558	CcSEcCtD
Glimepiride—Jaundice—Etoposide—muscle cancer	0.00425	0.00556	CcSEcCtD
Glimepiride—Leukopenia—Dactinomycin—muscle cancer	0.00422	0.00551	CcSEcCtD
Glimepiride—Agranulocytosis—Etoposide—muscle cancer	0.00407	0.00532	CcSEcCtD
Glimepiride—Diabetes mellitus—Methotrexate—muscle cancer	0.0039	0.00509	CcSEcCtD
Glimepiride—Anaemia—Vincristine—muscle cancer	0.00389	0.00508	CcSEcCtD
Glimepiride—Agitation—Vincristine—muscle cancer	0.00387	0.00505	CcSEcCtD
Glimepiride—Aplastic anaemia—Doxorubicin—muscle cancer	0.0038	0.00496	CcSEcCtD
Glimepiride—Hepatic failure—Methotrexate—muscle cancer	0.00377	0.00493	CcSEcCtD
Glimepiride—Leukopenia—Vincristine—muscle cancer	0.00377	0.00492	CcSEcCtD
Glimepiride—Thrombocytopenia—Dactinomycin—muscle cancer	0.00377	0.00492	CcSEcCtD
Glimepiride—Erythema multiforme—Etoposide—muscle cancer	0.0037	0.00484	CcSEcCtD
Glimepiride—Coma—Doxorubicin—muscle cancer	0.0037	0.00483	CcSEcCtD
Glimepiride—Anorexia—Dactinomycin—muscle cancer	0.00367	0.00479	CcSEcCtD
Glimepiride—Convulsion—Vincristine—muscle cancer	0.00365	0.00476	CcSEcCtD
Glimepiride—Hypertension—Vincristine—muscle cancer	0.00363	0.00475	CcSEcCtD
Glimepiride—Mental disability—Doxorubicin—muscle cancer	0.00351	0.00459	CcSEcCtD
Glimepiride—Cerebrovascular accident—Methotrexate—muscle cancer	0.00346	0.00452	CcSEcCtD
Glimepiride—Anaphylactic shock—Vincristine—muscle cancer	0.00344	0.00449	CcSEcCtD
Glimepiride—Diabetes mellitus—Doxorubicin—muscle cancer	0.00338	0.00441	CcSEcCtD
Glimepiride—Thrombocytopenia—Vincristine—muscle cancer	0.00336	0.00439	CcSEcCtD
Glimepiride—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00336	0.00439	CcSEcCtD
Glimepiride—Decreased appetite—Dactinomycin—muscle cancer	0.00334	0.00437	CcSEcCtD
Glimepiride—Hyperhidrosis—Vincristine—muscle cancer	0.00332	0.00434	CcSEcCtD
Glimepiride—Fatigue—Dactinomycin—muscle cancer	0.00332	0.00433	CcSEcCtD
Glimepiride—Anorexia—Vincristine—muscle cancer	0.00328	0.00428	CcSEcCtD
Glimepiride—Hepatic failure—Doxorubicin—muscle cancer	0.00327	0.00427	CcSEcCtD
Glimepiride—Hypotension—Vincristine—muscle cancer	0.00321	0.00419	CcSEcCtD
Glimepiride—Feeling abnormal—Dactinomycin—muscle cancer	0.00317	0.00414	CcSEcCtD
Glimepiride—Anaemia—Etoposide—muscle cancer	0.00315	0.00412	CcSEcCtD
Glimepiride—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00314	0.00411	CcSEcCtD
Glimepiride—Hot flush—Doxorubicin—muscle cancer	0.00314	0.0041	CcSEcCtD
Glimepiride—Increased appetite—Doxorubicin—muscle cancer	0.00313	0.00408	CcSEcCtD
Glimepiride—Menopausal symptoms—Doxorubicin—muscle cancer	0.00311	0.00407	CcSEcCtD
Glimepiride—Insomnia—Vincristine—muscle cancer	0.00311	0.00406	CcSEcCtD
Glimepiride—Paraesthesia—Vincristine—muscle cancer	0.00309	0.00403	CcSEcCtD
Glimepiride—Dermatitis bullous—Doxorubicin—muscle cancer	0.00307	0.00401	CcSEcCtD
Glimepiride—Leukopenia—Etoposide—muscle cancer	0.00305	0.00399	CcSEcCtD
Glimepiride—Abdominal pain—Dactinomycin—muscle cancer	0.00304	0.00397	CcSEcCtD
Glimepiride—Hypoglycaemia—Doxorubicin—muscle cancer	0.00301	0.00393	CcSEcCtD
Glimepiride—Loss of consciousness—Etoposide—muscle cancer	0.003	0.00392	CcSEcCtD
Glimepiride—Cerebrovascular accident—Doxorubicin—muscle cancer	0.003	0.00392	CcSEcCtD
Glimepiride—Decreased appetite—Vincristine—muscle cancer	0.00299	0.0039	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Vincristine—muscle cancer	0.00297	0.00387	CcSEcCtD
Glimepiride—Fatigue—Vincristine—muscle cancer	0.00296	0.00387	CcSEcCtD
Glimepiride—Convulsion—Etoposide—muscle cancer	0.00295	0.00386	CcSEcCtD
Glimepiride—Hyponatraemia—Doxorubicin—muscle cancer	0.00295	0.00385	CcSEcCtD
Glimepiride—Hypertension—Etoposide—muscle cancer	0.00294	0.00385	CcSEcCtD
Glimepiride—Pain in extremity—Doxorubicin—muscle cancer	0.00294	0.00384	CcSEcCtD
Glimepiride—Eosinophilia—Methotrexate—muscle cancer	0.0029	0.00379	CcSEcCtD
Glimepiride—Hypersensitivity—Dactinomycin—muscle cancer	0.00283	0.0037	CcSEcCtD
Glimepiride—Gastrointestinal pain—Vincristine—muscle cancer	0.00281	0.00367	CcSEcCtD
Glimepiride—Confusional state—Etoposide—muscle cancer	0.00281	0.00367	CcSEcCtD
Glimepiride—Pancytopenia—Methotrexate—muscle cancer	0.00278	0.00364	CcSEcCtD
Glimepiride—Anaphylactic shock—Etoposide—muscle cancer	0.00278	0.00364	CcSEcCtD
Glimepiride—Asthenia—Dactinomycin—muscle cancer	0.00276	0.0036	CcSEcCtD
Glimepiride—Thrombocytopenia—Etoposide—muscle cancer	0.00273	0.00356	CcSEcCtD
Glimepiride—Tachycardia—Etoposide—muscle cancer	0.00272	0.00355	CcSEcCtD
Glimepiride—Abdominal pain—Vincristine—muscle cancer	0.00272	0.00355	CcSEcCtD
Glimepiride—Hyperhidrosis—Etoposide—muscle cancer	0.00269	0.00351	CcSEcCtD
Glimepiride—Photosensitivity reaction—Methotrexate—muscle cancer	0.00268	0.0035	CcSEcCtD
Glimepiride—Anorexia—Etoposide—muscle cancer	0.00265	0.00347	CcSEcCtD
Glimepiride—Diarrhoea—Dactinomycin—muscle cancer	0.00263	0.00344	CcSEcCtD
Glimepiride—Drowsiness—Methotrexate—muscle cancer	0.00261	0.00341	CcSEcCtD
Glimepiride—Hypotension—Etoposide—muscle cancer	0.0026	0.0034	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00259	0.00339	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00259	0.00338	CcSEcCtD
Glimepiride—Abdominal distension—Doxorubicin—muscle cancer	0.00256	0.00334	CcSEcCtD
Glimepiride—Influenza—Doxorubicin—muscle cancer	0.00254	0.00332	CcSEcCtD
Glimepiride—Hypersensitivity—Vincristine—muscle cancer	0.00253	0.00331	CcSEcCtD
Glimepiride—Eosinophilia—Doxorubicin—muscle cancer	0.00251	0.00328	CcSEcCtD
Glimepiride—Sweating—Methotrexate—muscle cancer	0.00251	0.00327	CcSEcCtD
Glimepiride—Paraesthesia—Etoposide—muscle cancer	0.0025	0.00326	CcSEcCtD
Glimepiride—Dyspnoea—Etoposide—muscle cancer	0.00248	0.00324	CcSEcCtD
Glimepiride—Somnolence—Etoposide—muscle cancer	0.00247	0.00323	CcSEcCtD
Glimepiride—Angina pectoris—Doxorubicin—muscle cancer	0.00247	0.00323	CcSEcCtD
Glimepiride—Asthenia—Vincristine—muscle cancer	0.00247	0.00322	CcSEcCtD
Glimepiride—Vomiting—Dactinomycin—muscle cancer	0.00245	0.00319	CcSEcCtD
Glimepiride—Agranulocytosis—Methotrexate—muscle cancer	0.00244	0.00319	CcSEcCtD
Glimepiride—Rash—Dactinomycin—muscle cancer	0.00242	0.00317	CcSEcCtD
Glimepiride—Decreased appetite—Etoposide—muscle cancer	0.00242	0.00316	CcSEcCtD
Glimepiride—Pancytopenia—Doxorubicin—muscle cancer	0.00241	0.00315	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Etoposide—muscle cancer	0.0024	0.00314	CcSEcCtD
Glimepiride—Fatigue—Etoposide—muscle cancer	0.0024	0.00313	CcSEcCtD
Glimepiride—Diarrhoea—Vincristine—muscle cancer	0.00235	0.00307	CcSEcCtD
Glimepiride—Hepatitis—Methotrexate—muscle cancer	0.00235	0.00307	CcSEcCtD
Glimepiride—Pollakiuria—Doxorubicin—muscle cancer	0.00235	0.00306	CcSEcCtD
Glimepiride—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00232	0.00303	CcSEcCtD
Glimepiride—Weight increased—Doxorubicin—muscle cancer	0.00231	0.00302	CcSEcCtD
Glimepiride—Feeling abnormal—Etoposide—muscle cancer	0.00229	0.003	CcSEcCtD
Glimepiride—Nausea—Dactinomycin—muscle cancer	0.00228	0.00298	CcSEcCtD
Glimepiride—Gastrointestinal pain—Etoposide—muscle cancer	0.00228	0.00297	CcSEcCtD
Glimepiride—Dizziness—Vincristine—muscle cancer	0.00227	0.00297	CcSEcCtD
Glimepiride—Drowsiness—Doxorubicin—muscle cancer	0.00226	0.00296	CcSEcCtD
Glimepiride—Visual impairment—Methotrexate—muscle cancer	0.00226	0.00295	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00224	0.00293	CcSEcCtD
Glimepiride—Erythema multiforme—Methotrexate—muscle cancer	0.00222	0.0029	CcSEcCtD
Glimepiride—Urticaria—Etoposide—muscle cancer	0.00221	0.00289	CcSEcCtD
Glimepiride—Jaundice—Doxorubicin—muscle cancer	0.00221	0.00288	CcSEcCtD
Glimepiride—Abdominal pain—Etoposide—muscle cancer	0.0022	0.00287	CcSEcCtD
Glimepiride—Vomiting—Vincristine—muscle cancer	0.00218	0.00285	CcSEcCtD
Glimepiride—Sweating—Doxorubicin—muscle cancer	0.00217	0.00283	CcSEcCtD
Glimepiride—Rash—Vincristine—muscle cancer	0.00217	0.00283	CcSEcCtD
Glimepiride—Dermatitis—Vincristine—muscle cancer	0.00216	0.00283	CcSEcCtD
Glimepiride—Headache—Vincristine—muscle cancer	0.00215	0.00281	CcSEcCtD
Glimepiride—Agranulocytosis—Doxorubicin—muscle cancer	0.00211	0.00276	CcSEcCtD
Glimepiride—Bradycardia—Doxorubicin—muscle cancer	0.00207	0.0027	CcSEcCtD
Glimepiride—Hypersensitivity—Etoposide—muscle cancer	0.00205	0.00268	CcSEcCtD
Glimepiride—Erythema—Methotrexate—muscle cancer	0.00204	0.00267	CcSEcCtD
Glimepiride—Malnutrition—Methotrexate—muscle cancer	0.00204	0.00267	CcSEcCtD
Glimepiride—Nausea—Vincristine—muscle cancer	0.00204	0.00267	CcSEcCtD
Glimepiride—Hepatitis—Doxorubicin—muscle cancer	0.00203	0.00265	CcSEcCtD
Glimepiride—Asthenia—Etoposide—muscle cancer	0.002	0.00261	CcSEcCtD
Glimepiride—Pruritus—Etoposide—muscle cancer	0.00197	0.00257	CcSEcCtD
Glimepiride—Visual impairment—Doxorubicin—muscle cancer	0.00196	0.00256	CcSEcCtD
Glimepiride—Vision blurred—Methotrexate—muscle cancer	0.00193	0.00251	CcSEcCtD
Glimepiride—Erythema multiforme—Doxorubicin—muscle cancer	0.00192	0.00251	CcSEcCtD
Glimepiride—Diarrhoea—Etoposide—muscle cancer	0.0019	0.00249	CcSEcCtD
Glimepiride—Anaemia—Methotrexate—muscle cancer	0.00189	0.00247	CcSEcCtD
Glimepiride—Dizziness—Etoposide—muscle cancer	0.00184	0.0024	CcSEcCtD
Glimepiride—Leukopenia—Methotrexate—muscle cancer	0.00183	0.00239	CcSEcCtD
Glimepiride—Arrhythmia—Doxorubicin—muscle cancer	0.00182	0.00237	CcSEcCtD
Glimepiride—Convulsion—Methotrexate—muscle cancer	0.00177	0.00231	CcSEcCtD
Glimepiride—Vomiting—Etoposide—muscle cancer	0.00177	0.00231	CcSEcCtD
Glimepiride—Malnutrition—Doxorubicin—muscle cancer	0.00177	0.00231	CcSEcCtD
Glimepiride—Erythema—Doxorubicin—muscle cancer	0.00177	0.00231	CcSEcCtD
Glimepiride—Rash—Etoposide—muscle cancer	0.00175	0.00229	CcSEcCtD
Glimepiride—Dermatitis—Etoposide—muscle cancer	0.00175	0.00229	CcSEcCtD
Glimepiride—Headache—Etoposide—muscle cancer	0.00174	0.00228	CcSEcCtD
Glimepiride—Tension—Doxorubicin—muscle cancer	0.00174	0.00227	CcSEcCtD
Glimepiride—Nervousness—Doxorubicin—muscle cancer	0.00172	0.00224	CcSEcCtD
Glimepiride—Confusional state—Methotrexate—muscle cancer	0.00168	0.0022	CcSEcCtD
Glimepiride—Anaphylactic shock—Methotrexate—muscle cancer	0.00167	0.00218	CcSEcCtD
Glimepiride—Vision blurred—Doxorubicin—muscle cancer	0.00167	0.00218	CcSEcCtD
Glimepiride—Nausea—Etoposide—muscle cancer	0.00165	0.00216	CcSEcCtD
Glimepiride—Anaemia—Doxorubicin—muscle cancer	0.00163	0.00214	CcSEcCtD
Glimepiride—Thrombocytopenia—Methotrexate—muscle cancer	0.00163	0.00213	CcSEcCtD
Glimepiride—Agitation—Doxorubicin—muscle cancer	0.00163	0.00212	CcSEcCtD
Glimepiride—Hyperhidrosis—Methotrexate—muscle cancer	0.00161	0.00211	CcSEcCtD
Glimepiride—Anorexia—Methotrexate—muscle cancer	0.00159	0.00208	CcSEcCtD
Glimepiride—Leukopenia—Doxorubicin—muscle cancer	0.00158	0.00207	CcSEcCtD
Glimepiride—Palpitations—Doxorubicin—muscle cancer	0.00156	0.00204	CcSEcCtD
Glimepiride—Hypotension—Methotrexate—muscle cancer	0.00156	0.00203	CcSEcCtD
Glimepiride—Loss of consciousness—Doxorubicin—muscle cancer	0.00155	0.00203	CcSEcCtD
Glimepiride—Convulsion—Doxorubicin—muscle cancer	0.00153	0.002	CcSEcCtD
Glimepiride—Hypertension—Doxorubicin—muscle cancer	0.00153	0.00199	CcSEcCtD
Glimepiride—Insomnia—Methotrexate—muscle cancer	0.00151	0.00197	CcSEcCtD
Glimepiride—Anxiety—Doxorubicin—muscle cancer	0.0015	0.00196	CcSEcCtD
Glimepiride—Paraesthesia—Methotrexate—muscle cancer	0.0015	0.00196	CcSEcCtD
Glimepiride—Dyspnoea—Methotrexate—muscle cancer	0.00149	0.00194	CcSEcCtD
Glimepiride—Somnolence—Methotrexate—muscle cancer	0.00148	0.00194	CcSEcCtD
Glimepiride—Dry mouth—Doxorubicin—muscle cancer	0.00147	0.00192	CcSEcCtD
Glimepiride—Dyspepsia—Methotrexate—muscle cancer	0.00147	0.00192	CcSEcCtD
Glimepiride—Confusional state—Doxorubicin—muscle cancer	0.00146	0.0019	CcSEcCtD
Glimepiride—Decreased appetite—Methotrexate—muscle cancer	0.00145	0.00189	CcSEcCtD
Glimepiride—Anaphylactic shock—Doxorubicin—muscle cancer	0.00144	0.00189	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00144	0.00188	CcSEcCtD
Glimepiride—Fatigue—Methotrexate—muscle cancer	0.00144	0.00188	CcSEcCtD
Glimepiride—Shock—Doxorubicin—muscle cancer	0.00142	0.00186	CcSEcCtD
Glimepiride—Thrombocytopenia—Doxorubicin—muscle cancer	0.00141	0.00185	CcSEcCtD
Glimepiride—Tachycardia—Doxorubicin—muscle cancer	0.00141	0.00184	CcSEcCtD
Glimepiride—Hyperhidrosis—Doxorubicin—muscle cancer	0.0014	0.00182	CcSEcCtD
Glimepiride—Anorexia—Doxorubicin—muscle cancer	0.00138	0.0018	CcSEcCtD
Glimepiride—Feeling abnormal—Methotrexate—muscle cancer	0.00137	0.00179	CcSEcCtD
Glimepiride—Gastrointestinal pain—Methotrexate—muscle cancer	0.00136	0.00178	CcSEcCtD
Glimepiride—Hypotension—Doxorubicin—muscle cancer	0.00135	0.00176	CcSEcCtD
Glimepiride—Urticaria—Methotrexate—muscle cancer	0.00132	0.00173	CcSEcCtD
Glimepiride—Abdominal pain—Methotrexate—muscle cancer	0.00132	0.00172	CcSEcCtD
Glimepiride—Insomnia—Doxorubicin—muscle cancer	0.00131	0.00171	CcSEcCtD
Glimepiride—Paraesthesia—Doxorubicin—muscle cancer	0.0013	0.00169	CcSEcCtD
Glimepiride—Dyspnoea—Doxorubicin—muscle cancer	0.00129	0.00168	CcSEcCtD
Glimepiride—Somnolence—Doxorubicin—muscle cancer	0.00128	0.00168	CcSEcCtD
Glimepiride—Dyspepsia—Doxorubicin—muscle cancer	0.00127	0.00166	CcSEcCtD
Glimepiride—Decreased appetite—Doxorubicin—muscle cancer	0.00125	0.00164	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00125	0.00163	CcSEcCtD
Glimepiride—Fatigue—Doxorubicin—muscle cancer	0.00124	0.00163	CcSEcCtD
Glimepiride—Hypersensitivity—Methotrexate—muscle cancer	0.00123	0.0016	CcSEcCtD
Glimepiride—Asthenia—Methotrexate—muscle cancer	0.0012	0.00156	CcSEcCtD
Glimepiride—Feeling abnormal—Doxorubicin—muscle cancer	0.00119	0.00155	CcSEcCtD
Glimepiride—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00118	0.00154	CcSEcCtD
Glimepiride—Pruritus—Methotrexate—muscle cancer	0.00118	0.00154	CcSEcCtD
Glimepiride—Urticaria—Doxorubicin—muscle cancer	0.00115	0.0015	CcSEcCtD
Glimepiride—Abdominal pain—Doxorubicin—muscle cancer	0.00114	0.00149	CcSEcCtD
Glimepiride—Diarrhoea—Methotrexate—muscle cancer	0.00114	0.00149	CcSEcCtD
Glimepiride—Dizziness—Methotrexate—muscle cancer	0.0011	0.00144	CcSEcCtD
Glimepiride—Hypersensitivity—Doxorubicin—muscle cancer	0.00106	0.00139	CcSEcCtD
Glimepiride—Vomiting—Methotrexate—muscle cancer	0.00106	0.00138	CcSEcCtD
Glimepiride—Rash—Methotrexate—muscle cancer	0.00105	0.00137	CcSEcCtD
Glimepiride—Dermatitis—Methotrexate—muscle cancer	0.00105	0.00137	CcSEcCtD
Glimepiride—Headache—Methotrexate—muscle cancer	0.00104	0.00136	CcSEcCtD
Glimepiride—Asthenia—Doxorubicin—muscle cancer	0.00104	0.00135	CcSEcCtD
Glimepiride—Pruritus—Doxorubicin—muscle cancer	0.00102	0.00133	CcSEcCtD
Glimepiride—Nausea—Methotrexate—muscle cancer	0.00099	0.00129	CcSEcCtD
Glimepiride—Diarrhoea—Doxorubicin—muscle cancer	0.000988	0.00129	CcSEcCtD
Glimepiride—Dizziness—Doxorubicin—muscle cancer	0.000955	0.00125	CcSEcCtD
Glimepiride—Vomiting—Doxorubicin—muscle cancer	0.000918	0.0012	CcSEcCtD
Glimepiride—Rash—Doxorubicin—muscle cancer	0.00091	0.00119	CcSEcCtD
Glimepiride—Dermatitis—Doxorubicin—muscle cancer	0.000909	0.00119	CcSEcCtD
Glimepiride—Headache—Doxorubicin—muscle cancer	0.000904	0.00118	CcSEcCtD
Glimepiride—Nausea—Doxorubicin—muscle cancer	0.000857	0.00112	CcSEcCtD
